Skip to main content
. 2011 Jan 7;88(1):42–56. doi: 10.1016/j.ajhg.2010.11.013

Table 4.

CC Adult Score Derivation

Population Risk Relative Risk (Referral/Community) Relative Risk (Mutants/Community) Weight
Neurological

Macrocephaly, presence 2 10.7 30.1 6
Extreme (male, OFC ≥ 63 cm) 0.2 130 160 10
Extreme (female, OFC ≥ 60 cm) 0.2 20 170 10
Lhermitte Duclos disease 0.01 80 860 10
Autism or developmental delay 5 0.2 1.2 1

Breast and Gynecological

Invasive breast cancer
<30 0.06 23.3 23.3 4
30–39 0.43 20.2 19.8 4
40–49a 1.45 17.3 12.6 2
≥50 10.93 3 1.8 1
Fibrocystic breast disease 10 4.5 4.2 1
Endometrial cancer
20–29 0.01 50 140 10
30–39 0.06 20 46.7 6
40–49 0.19 13.7 36.8 6
≥50 2.43 3.7 2.9 1
Fibroids 13 3.2 2.9 1

Gastrointestinal

Polyposis syndrome (five or more, any type) 1 3.7 34.3 6
Intestinal hamartoma or ganglioneuroma, any number 0.01 10
Glycogenic acanthosis 0.01 100 1520 10

Skin

Trichilemmomas, biopsy proven 0.01 60 570 10
Oral papillomas 0.46 17.4 33 6
Penile freckling 1 18.8 29.4 6
Acral keratoses 10 0.6 2.7 1
Arteriovenous malformations 0.25 3.6 45.6 6
Skin lipomas 20 1.3 2.1 1

Endocrine

Thyroid cancer
<20 0.01 90 480 10
20–29a 0.06 46.7 48.3 4
30–39a 0.13 44.6 51.5b 4
40–49a 0.17 43.5 44.7 4
≥50a 0.57 17.7 6.7 1
Thyroid goiter, nodules, adenomas, or Hashimoto's thyroiditis (one or more features) 5 7.1 14.4 4

Genitourinary

Renal cell carcinoma 1.49 3.2 4.5 1
a

For these specific features, referral bias was clinically recognized and accounted for by a standard downward modification of weight by a risk tier; this bias may also be recognized in a high RR (study population/community, relative to the RR in patients with PTEN mutations/community). Individual features for which high referral bias was evident, but where weight was already 1, were not further adjusted downward.

b

For this borderline RR just above the threshold of 50, given the relatively consistent RRs in adjacent groups for all populations, this weight was adjusted to 4 for consistency between the adjacent age groups.